Caspase-8 gene therapy using the human telomerase reverse transcriptase promoter for malignant glioma cells

Human Gene Therapy

Volumn 13, Issue 9, 2002, Pages 1015-1025

  Komata, Tadashi ^a,b   Kondo, Yasuko ^a,b   Kanzawa, Takao ^b   Ito, Hideaki ^b   Hirohata, Satoshi ^a   Koga, Shoji ^a   Sumiyoshi, Hideaki ^b   Takakura, Masahiro ^c   Inoue, Masaki ^c   Barna, Barbara P ^d   Germano, Isabelle M ^b   Kyo, Satoru ^c   Kondo, Seiji ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c KANAZAWA UNIVERSITY   (Japan)

^d METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; RECOMBINANT DNA; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ANIMAL MODEL; APOPTOSIS; ARTICLE; ASTROCYTE; BASE PAIRING; CANCER CELL; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FIBROBLAST; GENE CONSTRUCT; GENE EXPRESSION SYSTEM; GENE THERAPY; GENETIC TRANSCRIPTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PROMOTER REGION; PROSTATE CANCER; TRANSCRIPTION INITIATION; TUMOR GROWTH;

ANIMALS; APOPTOSIS; CASPASE 8; CASPASE 9; CASPASES; CELLS, CULTURED; DNA-BINDING PROTEINS; FEMALE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GLIOMA; HUMANS; MALE; MICE; MICE, NUDE; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TELOMERASE; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0036288826     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303402753812421     Document Type: Article

References (42)

1. Apoptosis, cancer and cancer therapy
2. Telomerase activity in normal and malignant hematopoietic cells
3. Caspases: The executioners of apoptosis
4. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity
5. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: An analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991
6. Brain tumor working group report on the 9th international conference on brain tumor research and therapy
7. Mechanisms and functions of cell death
8. Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis
9. Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers
10. Telomerase activity in primary and secondary glioblastomas multiforme as a novel molecular tumor marker
11. Telomerase activity in small-cell and non-small-cell lung cancers
12. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene
13. Correlation of clinical features and telomerase activity in human gliomas
14. Specific association of human telomerase activity with immortal cells and cancer
15. A novel telomerase-specific gene therapy: Gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter
16. Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53
17. Interleukin-1β-converting enzyme mediates cisplatin-induced apoptosis in malignant glioma cells
18. Retroviral transfer of CPP32β gene into malignant gliomas in vitro and in vivo
19. Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA
20. Telomerase activity in human brain tumours
21. Telomerase activity in human gliomas
22. Kip1, is required for IL-4 regulation of astrocyte proliferation
23. National survey of patterns of care for brain-tumor patients
24. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters
25. Signaling pathway activated during apoptosis of the prostate cancer cell line LNCaP: Overexpression of caspase-7 as a new gene therapy strategy for prostate cancer
26. Implications of apoptotic cell death regulation in cancer therapy
27. Selective astrocytic transgene expression in vitro andin vivo from the GFAP promoter in a HSV RL1 null mutant vector-potential glioblastoma targeting
28. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization
29. Differential susceptibility of primary and established human glioma cells to adenovirus infection: Targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer
30. 2-5A antisense telomerase RNA therapy for intracranial malignant gliomas
31. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex
32. Telomerase catalytic subunit homologs from fission yeast and human
33. Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene
34. Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer
35. Oncology of the nervous system
36. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells
37. Apoptosis in the pathogenesis and treatment of disease
38. Progesterone regulates human telomerase reverse transcriptase gene expression via activation of mitogen-activated protein kinase signaling pathway
39. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT
40. Cell death: The significance of apoptosis
41. Autoproteolytic activation of pro-caspases by oligomerization
42. Retroviral delivery and tetracycline-dependent expression of IL-1β-converting enzyme (ICE) in a rat glioma model provides controlled induction of apoptotic death in tumor cells